Status:
COMPLETED
Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas
Lead Sponsor:
University of Utah
Conditions:
Dermatofibroma of Skin
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study is to find a more effective treatment for itchy, painful or unsightly dermatofibromas, that will improve symptoms of itch and/or pain and/or improve the appearance of dermatofibromas. This ...
Detailed Description
The main objective of this study is to find a more effective treatment for itchy, painful or unsightly dermatofibromas, that will improve symptoms of itch and/or pain and/or improve the appearance of ...
Eligibility Criteria
Inclusion
- female or male, age 18-65, have at least one dermatofibroma of the skin, on the trunk or extremities, diagnosed by dermatologist, dermatofibroma is either itchy, painful or unattractive to the patient.
Exclusion
- previous treatment to the dermatofibroma(s), pregnant or nursing women, diabetic, smoker, psoriasis, lupus or other autoimmune diseases, patient with a clear history of keloids or poor wound healing. This study will exclude dermatofibroma lesions on the face and genitals.
Key Trial Info
Start Date :
November 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT03392935
Start Date
November 30 2017
End Date
March 31 2021
Last Update
May 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah Dermatology
Salt Lake City, Utah, United States, 84132